Mimedx EV/EBIT MDXG

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2015.

Today, Oct 23, 2026: 51.6×
10-year median: 20.0×
Against its 10-year history: 82nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 2.9× to 117×
Peer median: 20.8×

Mimedx's EV/EBIT is 51.6× as of Oct 23, 2026.

That is above its ten-year median of 20.0×, higher than on 82% of days in the last ten years.

Over that time it ranged from 2.9× in Dec 2018 to 117× in Sep 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 20.8×.

EV/EBIT over time

median 20×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	51.6×	5.6×	65.9×
2025	16.6×	14.2×	22.7×
2024	20.7×	12.4×	35.3×
2023	37.8×	25.2×	117×
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	16.6×	10.2×	25.9×
2019	24.8×	6.2×	25.4×
2018	4.2×	2.9×	60.6×
2017	44.1×	38.6×	73.9×
2016	54.5×	30.2×	61.4×
2015	45.8×	37.5×	156×

Against its peers

Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.

Company	EV/EBIT
MDXGMimedx	51.6×
TCMDTactile Systems Technology	13.3×
MOVMovado	11.8×
EMBCEmbecta	6.7×
IRMDIradimed	37.7×
STAAStaar Surgical	57.7×
INFUInfuSystem	22.4×
BVSBioventus	26.2×
CDRECadre	23.2×
UTMDUtah Medical Products	6.0×
EYENational Vision	19.2×
Peer median	20.8×

Where Mimedx ranks

#40of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Mimedx

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.